M Chonchol
Overview
Explore the profile of M Chonchol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blaine J, Chonchol M, Levi M
Clin J Am Soc Nephrol
. 2015 Sep;
10(10):1886-7.
PMID: 26384363
No abstract available.
2.
Jablonski K, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al.
Nutr Metab Cardiovasc Dis
. 2013 Feb;
23(8):792-8.
PMID: 23415456
Background And Aims: We sought to explore associations between serum 25-hydroxyvitamin D [25(OH)D] levels and non-alcoholic fatty liver disease [NAFLD] in an integrated healthcare delivery system in the U.S. Methods...
3.
van de Luijtgaarden K, Voute M, Hoeks S, Bakker E, Chonchol M, Stolker R, et al.
Eur J Vasc Endovasc Surg
. 2012 Jul;
44(3):301-6.
PMID: 22841360
Objectives: The aim of this study was to assess the vitamin D status in patients with occlusive or aneurysmatic arterial disease in relation to clinical cardiovascular risk profiles and markers...
4.
Bakker E, Ravensbergen N, Voute M, Hoeks S, Chonchol M, Klimek M, et al.
Eur J Vasc Endovasc Surg
. 2011 Jun;
42(3):317-23.
PMID: 21632265
Objectives: This article describes the rationale and design of the DECREASE-XIII trial, which aims to evaluate the potential of esmolol infusion, an ultra-short-acting beta-blocker, during surgery as an add-on to...
5.
Targher G, Chonchol M, Pichiri I, Zoppini G
J Endocrinol Invest
. 2011 Mar;
34(7):544-51.
PMID: 21427524
Non-alcoholic fatty liver disease (NAFLD) is estimated to afflict ~20-30% of the general population, and over 70% of the patients with Type 2 diabetes. Given the expected rise in the...
6.
Winkel T, Schouten O, Hoeks S, Voute M, Chonchol M, Goei D, et al.
Eur J Vasc Endovasc Surg
. 2010 Oct;
40(6):739-46.
PMID: 20884259
Background: Cardiac troponin T (cTnT) assays with increased sensitivity might increase the number of positive tests. Using the area under the curve (AUC) with serial sampling of cTnT an exact...
7.
Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, et al.
Diabetologia
. 2010 Apr;
53(7):1341-8.
PMID: 20369224
Aims/hypothesis: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased prevalence of chronic kidney disease (CKD) and retinopathy in patients with type 2 diabetes. Information on this issue is...
8.
Targher G, Zoppini G, Chonchol M, Negri C, Stoico V, Perrone F, et al.
Nutr Metab Cardiovasc Dis
. 2010 Jan;
21(4):294-301.
PMID: 20096544
Background And Aims: To assess all-cause and cardiovascular mortality in type 2 diabetic individuals according to estimated glomerular filtration rate (eGFR) and albuminuria. Methods And Results: We followed 2823 type...
9.
Targher G, Kendrick J, Smits G, Chonchol M
Nutr Metab Cardiovasc Dis
. 2009 Aug;
20(8):583-90.
PMID: 19699624
Background And Aims: Elevated serum levels of gamma-glutamyltransferase (GGT) are a marker of liver injury, but may also be associated with other diseases and death. Currently, the association of serum...
10.
Chonchol M, Katz R, Fried L, Sarnak M, Siscovick D, Newman A, et al.
Nutr Metab Cardiovasc Dis
. 2009 Apr;
20(1):15-21.
PMID: 19364638
Background And Aims: Glycosylated hemoglobin (HbA(1c)) has been associated with incident cardiovascular disease (CVD), but the findings are inconsistent. We tested the hypothesis that HbA(1c) may be associated with an...